NUBYTIDE
Live / Applied — Second extension granted (statement of use) (as of 23 Dec 2025)
What this means for you
Not registered yet, but its 27 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98286932
- Mark type
- Stylized text
- Filed
- 27 Nov 2023
- Published for opposition
- 12 Nov 2024
- Attorney of record
- Jianmin Zhou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Alzheimer's
Owner
- Cenna Biosciences Inc., La Jolla, CA, US
- Cenna Biosciences Inc., La Jolla, CA, US
Prosecution history
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Dec 2025 — SOU EXTENSION 2 GRANTED
- 23 Dec 2025 — SOU EXTENSION 2 FILED
- 23 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2025 — SOU EXTENSION 1 GRANTED
- 23 Jun 2025 — SOU EXTENSION 1 FILED
- 03 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Aug 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 12 Aug 2025 — NOTICE OF REVIVAL - E-MAILED
- 12 Aug 2025 — PETITION TO REVIVE-GRANTED
- 12 Aug 2025 — TEAS PETITION TO REVIVE RECEIVED
- 28 Jul 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Jul 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT